Every Form 4 that GDEV Inc. (GDEV) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow GDEV and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full GDEV filings page.
GDEV Inc. insider Anton Reingold, who serves as Chief Executive Officer of Nexters Global Ltd., reported an option exercise and related share movements. On 2026-08-21, he exercised a fully vested stock option for 22,072 Ordinary Shares at a conversion price of $0.00 per share. In connection with this exercise, 3,863 Ordinary Shares were delivered or withheld at $11.24 per share for payment of the exercise price or tax liability. The exercised stock option position was reduced to 0 derivative shares after the transaction.
GDEV Inc. director Andrew Jeremy Sheppard exercised a fully vested stock option for 7,906 Ordinary Shares on 2026-08-11. The derivative position in this option was reduced to zero, and his directly held Ordinary Shares increased to 8,418 following the transaction.
GDEV Inc. director Marie Juliette France Holive received a grant of stock options covering 7,906 Ordinary Shares. The options were awarded at an exercise price of $0.00 per share, are fully vested and exercisable, and expire on November 16, 2031. Following the grant, she holds 7,906 derivative securities directly.
GDEV Inc. director Andrew Jeremy Sheppard reported receiving a grant of stock options for 7,906 underlying ordinary shares. The options are fully vested and exercisable at an exercise price of $0.00 per share and expire on November 16, 2031. Following this grant, Sheppard holds stock options covering 7,906 shares directly.
GDEV Inc. director Shoham Tal received a grant of stock options covering 7,906 ordinary shares. These options were awarded as a grant or award acquisition at an exercise price of $0.00 per share and are fully vested and exercisable.
Following this grant, Tal holds stock options for a total of 18,560 shares. This is a routine compensation-related equity award, not an open‑market purchase or sale of GDEV shares.
GDEV Inc. director Marie Juliette France Holive reported an open-market sale of company stock. On June 3, 2026, she sold 10,654 Ordinary Shares at an average price of $13.45 per share. Following this transaction, her directly held Ordinary Shares position reported in this filing was reduced to zero.